Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.240
+0.020 (0.47%)
At close: Oct 15, 2026, 4:00 PM EDT
4.260
+0.020 (0.47%)
After-hours: Oct 15, 2026, 7:40 PM EDT
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Vanda Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $11.75. The average 1-year stock price forecast is 177.12% higher than the current stock price, while the lowest is $5.75 (+35.61%) and the highest is $20 (+371.70%).
Price Target: $11.75 (+177.12%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vanda Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +371.70% | Oct 5, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +135.85% | Sep 23, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $17 → $12 | Buy | Initiates | $17 → $12 | +183.02% | Aug 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +159.43% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
248.88M
from 216.11M
Increased by 15.16%
Revenue Next Year
337.22M
from 248.88M
Increased by 35.50%
EPS This Year
0.96
EPS Next Year
1.04
from 0.96
Increased by 8.33%
EPS and Forward PE are based on non-GAAP adjusted numbers.